IRC
ABBV icon

Investors Research Corp’s AbbVie ABBV Stock Holding History

Investors Research Corp’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69.2K Hold
275
– – 0.01% 365
2026
Q1 		$59.8K Sell
275
-481
-64% -$107K 0.01% 380
2025
Q4 		$173K Sell
756
-170
-18% -$38.7K 0.03% 310
2025
Q3 		$214K Buy
926
+80
+9% +$16.3K 0.04% 291
2025
Q2 		$157K Hold
846
– – 0.03% 333
2025
Q1 		$177K Buy
846
+105
+14% +$20.4K 0.04% 307
2024
Q4 		$132K Hold
741
– – 0.03% 355
2024
Q3 		$146K Hold
741
– – 0.03% 348
2024
Q2 		$127K Hold
741
– – 0.03% 373
2024
Q1 		$135K Sell
741
-1,233
-62% -$212K 0.03% 367
2023
Q4 		$306K Hold
1,974
– – 0.07% 274
2023
Q3 		$294K Hold
1,974
– – 0.08% 272
2023
Q2 		$266K Buy
1,974
+17
+0.9% +$2.49K 0.07% 293
2023
Q1 		$312K Hold
1,957
– – 0.08% 270
2022
Q4 		$316K Hold
1,957
– – 0.09% 263
2022
Q3 		$263K Buy
1,957
+22
+1% +$3.16K 0.08% 270
2022
Q2 		$296K Buy
1,935
+287
+17% +$43.9K 0.09% 259
2022
Q1 		$267K Sell
1,648
-13,487
-89% -$1.96M 0.08% 281
2021
Q4 		$2.05M Hold
15,135
– – 0.62% 39
2021
Q3 		$1.63M Hold
15,135
– – 0.55% 46
2021
Q2 		$1.71M Buy
15,135
+59
+0.4% +$6.64K 0.59% 38
2021
Q1 		$1.63M Sell
15,076
-275
-2% -$29.4K 0.61% 22
2020
Q4 		$1.65M Sell
15,351
-100
-0.6% -$9.61K 0.65% 17
2020
Q3 		$1.35M Sell
15,451
-300
-2% -$28.2K 0.66% 19
2020
Q2 		$1.55M Buy
15,751
+98
+0.6% +$8.63K 0.78% 14
2020
Q1 		$1.19M Sell
15,653
-50
-0.3% -$4.26K 0.74% 12
2019
Q4 		$1.39M Sell
15,703
-25
-0.2% -$2.08K 0.64% 17
2019
Q3 		$1.19M Sell
15,728
-150
-0.9% -$10.3K 0.6% 23
2019
Q2 		$1.16M Buy
15,878
+13,825
+673% +$1.09M 0.6% 27
2019
Q1 		$165K Buy
+2,053
New +$168K 0.09% 294

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Investors Research Corp's ABBV Position: Q2 2026 in Review

Investors Research Corp held its AbbVie (ABBV) position steady in Q2 2026 at 275 shares worth $69.2K. The position accounts for 0.01% of the portfolio, ranked #365.

Investors Research Corp first reported a position in ABBV in Q1 2019 and has held it in 30 quarters since. The position peaked at $2.05M in Q4 2021. 1,316 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Investors Research Corp held 275 shares of AbbVie worth $69.2K as of Q2 2026.
  • Investors Research Corp left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.01% of Investors Research Corp's portfolio in Q2 2026, its #365 holding.
  • Investors Research Corp first reported a position in AbbVie in Q1 2019 and has held it in 30 quarters since.
  • Investors Research Corp's AbbVie position peaked at $2.05M in Q4 2021.
  • 1,316 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Investors Research Corp's 13F filing for Q2 2026, filed 10 Jul 2026.